What is cilostazol used for?

What condition does cilostazol treat?

Cilostazol is primarily used to manage the symptoms of intermittent claudication, a condition characterized by pain, cramping, or fatigue in the legs due to reduced blood flow [1]. It is an antiplatelet and vasodilatory medication that aims to improve blood circulation and reduce the frequency and severity of painful episodes.

How does cilostazol work in the body?

Cilostazol inhibits the activity of phosphodiesterase III, an enzyme that regulates blood flow by causing blood vessels to constrict. By inhibiting this enzyme, cilostazol helps to dilate blood vessels and improve blood circulation to the extremities [1].

Can cilostazol improve walking ability in patients with peripheral artery disease?

Studies suggest that cilostazol can improve walking distance and reduce symptoms of intermittent claudication in patients with peripheral artery disease [2]. A meta-analysis of clinical trials found that cilostazol significantly increased walking distance and reduced the severity of symptoms in patients with peripheral artery disease.

Is cilostazol a widely available treatment option?

Cilostazol is approved for use in the United States and other countries for the treatment of intermittent claudication [3]. However, its availability and use may vary depending on the country and region.

What are the potential side effects of cilostazol?

Common side effects of cilostazol include headache, diarrhea, and dizziness [1]. More serious side effects, such as bleeding and cardiac issues, can also occur, although they are less common.

References

[1] DrugPatentWatch.com. (n.d.). Cilostazol. Retrieved from https://www.drugpatentwatch.com/drug/cilostazol

[2] Lee S, et al. (2014). Meta-analysis of cilostazol for intermittent claudication. Journal of Cardiovascular Medicine, 15(12), 731-738.

[3] FDA.gov. (n.d.). Cilostazol. Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/cilostazol